This inventor holds 1 USPTO granted patent. Top assignee: Cosmo Bio Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Chihiro Okada: Innovator in Monoclonal Antibody Development
Introduction
Chihiro Okada is a prominent inventor based in Toyonaka, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her innovative work has the potential to enhance the detection of exosomes, which are crucial in various biological processes.
Latest Patents
Chihiro Okada holds a patent for a monoclonal antibody designed for detecting exosomes. This invention includes antibodies that recognize specific amino acid sequences, allowing for the detection of CD9, CD63, or CD81 on exosomes with excellent sensitivity and specificity. The patent represents a significant advancement in the ability to capture and analyze exosomes in living organisms.
Career Highlights
Chihiro Okada is associated with Cosmo Bio Co., Ltd., where she has been instrumental in advancing research and development in her field. Her work has garnered attention for its potential applications in diagnostics and therapeutic interventions.
Collaborations
Chihiro has collaborated with notable colleagues, including Hideki Ohta and Tomi Murakami. These partnerships have contributed to the success of her research and the development of her patented technologies.
Conclusion
Chihiro Okada's contributions to the field of monoclonal antibodies exemplify her innovative spirit and dedication to advancing biotechnology. Her work continues to pave the way for new diagnostic tools and therapeutic strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile